Cargando…
Pharmacokinetics of bevacizumab after topical and intravitreal administration in human eyes
BACKGROUND: Topical bevacizumab is a potential treatment modality for corneal neovascularization, and several recent studies have demonstrated its efficacy. No previous study of the pharmacokinetics of topical bevacizumab has been performed in human eyes. The purpose of this study is to investigate...
Autores principales: | Moisseiev, Elad, Waisbourd, Michael, Ben-Artsi, Elad, Levinger, Eliya, Barak, Adiel, Daniels, Tad, Csaky, Karl, Loewenstein, Anat, Barequet, Irina S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3912353/ https://www.ncbi.nlm.nih.gov/pubmed/24170282 http://dx.doi.org/10.1007/s00417-013-2495-0 |
Ejemplares similares
-
A matched-control comparison of serious adverse events after intravitreal injections of bevacizumab for age-related macular degeneration and cataract extraction
por: Fischer, Naomi, et al.
Publicado: (2013) -
Macular Hole following Intravitreal Bevacizumab Injection in Choroidal Neovascularization Caused by Age-Related Macular Degeneration
por: Moisseiev, Elad, et al.
Publicado: (2010) -
Optic disc pit maculopathy: when and how to treat? A review of the pathogenesis and treatment options
por: Moisseiev, Elad, et al.
Publicado: (2015) -
Endophthalmitis After Intravitreal Bevacizumab (Avastin) Injections: An Outbreak Investigated
por: Shoaib, Khawaja K, et al.
Publicado: (2023) -
The safety of intravitreal bevacizumab monotherapy in adult ophthalmic conditions: systematic review
por: Poku, Edith, et al.
Publicado: (2014)